ESC 365 - Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction

ESC Premium Access

Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction

Session: Diagnosis and prognosis of HFpEF

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor A. Tada (Rochester, US)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Atsushi Tada

Mayo Clinic, Rochester (United States of America)

0 follower

3 more presentations in this session

Estimated transmitral E- and A-wave overlapping predicted prognosis in patient with heart failure with preserved ejection.

Speaker: Doctor K. Iwakura (Osaka, JP)

Diagnosis of heart failure with preserved ejection fraction based on exercise stress echocardiography in real-world practice

Speaker: Mr Y. Tani (Maebashi, JP)

Diagnosing heart failure with preserved ejection fraction in patients with unexplained dyspnoea using left ventricular pressure-volume loops at rest and on exertion

Speaker: Doctor R. Gessner (Leipzig, DE)

Access the full session

Diagnosis and prognosis of HFpEF

Speakers: Doctor A. Tada, Doctor K. Iwakura, Mr Y. Tani, Doctor R. Gessner

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources